Walter J Koroshetz. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Anticoagulants/therapeutic useAspirin/therapeutic useDose-Response Relationship, DrugFibrinolytic Agents/therapeutic useHemorrhage/chemically inducedHumansIntracranial Arteriosclerosis/complicationsIntracranial Arteriosclerosis/drug therapyIschemic Attack, Transient/prevention & controlMortalityStroke/prevention & controlThromboembolism/diagnosisTreatment FailureWarfarin/therapeutic use
Substances: See more » AnticoagulantsFibrinolytic AgentsWarfarinAspirin
Year: 2005 PMID: 15800233 DOI: 10.1056/NEJMe058022
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245